You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ribavirin

Showing 51 - 75 of 363
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
May 1, 2019

Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in

Completed
Has Results
  • Chronic Hepatitis C, Genotype 1 or 4
  • (no location specified)
Feb 6, 2019

Hepatitis C Virus Trial (Paritaprevir, Ritonavir, Dasabuvir)

Unknown status
  • Hepatitis C Virus
  • (no location specified)
Oct 4, 2019

HCV Coinfection Trial in Assiut (Sofosbuvir, Simeprevir, Daclatasvir)

Completed
  • HCV Coinfection
  • Assiut, Egypt
    Assiut University Hopsital
Mar 17, 2019

Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis

Unknown status
  • Chronic Hepatitis C
  • Beijing, Beijing, China
    liver disease center, Beijing Ditan Hospital
Aug 25, 2019

Hepatitis C, Cirrhosis Trial in Coronado (daclatasvir, Sofosbuvir, Sovaldi, Ribavirin)

Completed
Has Results
  • Hepatitis C
  • Cirrhosis
  • Coronado, California
    Southern California Research Center
Apr 23, 2019

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Mar 26, 2019

Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

Completed
Has Results
  • Chronic Hepatitis C
  • (no location specified)
Oct 22, 2018

Hepatitis C Trial in Kaohsiung (daclatasvir, asunaprevir, Ribavirin)

Completed
  • Hepatitis C
  • Kaohsiung, Taiwan
    Kaohsiung Medical Universsity
Jan 7, 2019

Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Jul 10, 2019

Insulin Resistance Trial in Geneva (Ledipasvir 90 mg/Sofosbuvir 400 mg, Ribavirin)

Completed
  • Insulin Resistance
  • Ledipasvir 90 mg/Sofosbuvir 400 mg
  • Ribavirin
  • Geneva, GE, Switzerland
    Division of Gastroenterology and hepatology, University Hospital
Apr 29, 2019

Hepatitis C Virus Trial in Worldwide (Peginterferon Lambda-1a, Peginterferon Alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • Peginterferon Lambda-1a
  • +3 more
  • Birmingham, Alabama
  • +103 more
Jul 29, 2019

Hepatitis, Hepatitis C, Digestive System Diseases Trial (MK-3682B, Ribavirin)

Terminated
Has Results
  • Hepatitis
  • +7 more
  • (no location specified)
Jul 15, 2019

Hepatitis C, Chronic Trial in Germany, Poland, Spain (Simeprevir, Daclatasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C, Chronic
  • Essen, Germany
  • +5 more
Nov 20, 2018

Hepatitis C Trial (Vaniprevir, Pegylated Interferon (peg-IFN), Ribavirin)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Sep 10, 2018

Hepatitis C, Chronic Trial in Kaohsiung (TG-2349, Ribavirin, Interferon Alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital
Sep 11, 2018

Herpangina Trial in Shanghai (Recombinant Human Interferon a-2b Spray, Ribavirin)

Completed
  • Herpangina
  • Recombinant Human Interferon α-2b Spray
  • Ribavirin
  • Shanghai, China
    Children's Hospital of Fudan University
Mar 6, 2019

Hepatitis C Trial (Peginterferon alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C
  • Peginterferon alfa-2a
  • Ribavirin
  • (no location specified)
Aug 30, 2018

Chronic Hepatitis C Trial in Poland (SD-101, ribavirin)

Completed
  • Chronic Hepatitis C
  • Bydgoszcz, Poland
  • +4 more
Apr 11, 2019

Hepatitis C Trial in Russian Federation (Narlaprevir, Ritonavir, Placebo Narlaprevir)

Completed
  • Hepatitis C
  • Chelyabinsk, Russian Federation
  • +19 more
Feb 5, 2019

Chronic Hepatitis C Virus (HCV) Trial (ABT-450/r/ABT-267, ABT-333, ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV)
  • (no location specified)
Feb 27, 2018

Handfoot-mouth Disease Trial in Shanghai (Ribavirin plus Xiao'er jiebiao oral liquid, Ribavirin)

Completed
  • Handfoot-mouth Disease
  • Ribavirin plus Xiao'er jiebiao oral liquid
  • Ribavirin
  • Shanghai, China
    Children's Hospital of Fudan University
Aug 5, 2018

Liver Disease Trial in New York, Dallas (sofosbuvir/ledipasvir, sofosbuvir, Ribavirin)

Terminated
Has Results
  • Liver Disease
  • New York, New York
  • +2 more
Jan 7, 2019

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Pegylated Interferon a-2a (PegINF))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +3 more
  • (no location specified)
May 2, 2018

Hepatitis C, Cirrhosis Trial in Tehran (Sofosbuvir, Ledipasvir, Ribavirin)

Completed
  • Hepatitis C
  • Cirrhosis
  • Tehran, Iran, Islamic Republic of
    Shariati Hospital
Apr 27, 2018